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A public health risk assessment for yellow fever vaccination: a model 
exemplified by an outbreak in the state of São Paulo, Brazil
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We propose a method to analyse the 2009 outbreak in the region of Botucatu in the state of São Paulo (SP), Brazil, 
when 28 yellow fever (YF) cases were confirmed, including 11 deaths. At the time of the outbreak, the Secretary of 
Health of the State of São Paulo vaccinated one million people, causing the death of five individuals, an unprec-
edented number of YF vaccine-induced fatalities. We apply a mathematical model described previously to optimise 
the proportion of people who should be vaccinated to minimise the total number of deaths. The model was used to 
calculate the optimum proportion that should be vaccinated in the remaining, vaccine-free regions of SP, consider-
ing the risk of vaccine-induced fatalities and the risk of YF outbreaks in these regions.
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Yellow fever (YF) is an haemorrhagic fever caused 
by the prototype member of the genus Flavivirus (a name 
which translates from Latin as “yellow virus”) family Fla-
viridae (Monath 2001, Moreno et al. 2011). This family 
comprises approximately 70 viruses (Moreno et al. 2011), 
most of which are transmitted by arthropod insects (hence 
the name arthropod born viruses or arboviruses). Genomic 
sequence analysis suggests that the YF virus evolved from 
other mosquito-borne viruses 3,000 years ago (Zanotto et 
al. 1996). It is an infection endemic in the tropical forests 
of Africa and Central and South America (Barnett 2004). 
In these regions, YF is enzootic and it is maintained by 
circulating in non-human primates and is transmitted by 
diurnally active mosquitoes (Haemagogus spp and Sa-
bethes spp in the Americas and Aedes spp in Africa). Dur-
ing occupational or recreational activities in forest areas, 
susceptible individuals are bitten by mosquitoes carrying 
the YF virus and develop the clinical disease with vary-
ing degrees of severity. These individuals may eventually 
return infected to their home cities, which is of particular 
concern in urban regions infested by Aedes aegypti (YF 
vector of the urban cycle of the disease), the same trans-
mitter of dengue fever and the mosquito responsible for 
huge YF outbreaks in urban centres in the past.
With 738 cases and 478 deaths, the last outbreak of 
urban YF in Brazil happened in Rio de Janeiro in 1928-
1929 and in 1942, Brazil was declared free of YF by the 
Pan American Health Organization (Monath 1991). In 
1958, the 20 year national campaign for the eradication 
of Ae. aegypti was successful and the mosquito disap-
peared from Brazilian cities. In 1967, the mosquito re-
infested the states of Pará and Maranhão, but this re-
infestation was short-lived and the mosquito was again 
eradicated in 1973. Unfortunately, in 1976 Ae. aegypti 
invaded Brazil again through the port of Salvador, state 
of Bahia, and spread throughout the country, infesting 
more than 80% of the Brazilian cities since then. Urban 
YF has never resurged and the diseased remained enzo-
otic, causing occasional sporadic human cases (Costa et 
al. 2011, Moreno & Barata 2011).
Recently, however, YF re-emerged in the Central 
and Southeast Regions of Brazil, causing 51 cases and 
21 deaths from 2008-2009 (Fortaleza et al. 2009). As a 
consequence, public health authorities intensified the YF 
vaccination programme. In the state of São Paulo (SP), 
approximately eight million doses of YF vaccine were ad-
ministered between 1999-2008. This amount corresponds 
to approximately 19% of the entire state population (cve.
saude.sp.gov.br/cgi/deftohtm.exe?cvetab/pnisp/pnidos.def).
In this paper, we propose a method to analyse the 
2009 outbreak in the region of Botucatu, SP, when 28 YF 
cases were confirmed, including 11 deaths (Mascheretti 
et al. 2013). At the time of the outbreak, the Secretary 
of Health of the State of São Paulo vaccinated one mil-
lion people, causing the death of five individuals, an 
unprecedented number of YF vaccine-induced fatali-
ties. We apply a mathematical model described previ-
ously to optimise the proportion of people who should 
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be vaccinated to minimise the total number of deaths 
(Massad et al. 2005). The model was used to calculate 
the optimum proportion that should be vaccinated in the 
remaining, vaccine-free regions of SP, considering the 
risk of vaccine-induced fatalities and the risk of YF out-
break in these regions. This work should be viewed as a 
methodological proposal rather than a definitive public 
health intervention policy.
MATERIALS AND METHODS
If p is the proportion of the population that is pre-
emptively vaccinated in campaigns before outbreaks, we 
can express the expected total number of deaths or serious 
adverse events, D(p), due to vaccination and potential YF 
outbreaks as (Bauch et al. 2003, Massad et al. 2005):
D(p) = Nh {pdv  + r(1- p)[pyf (p)dyf + pv(p)d*v  (p)]} 
where Nh is the size of the human population, dv is the probability of developing serious adverse events (includ-
ing deaths) after being pre-emptively vaccinated, r is the 
risk of an outbreak, dyf  is the probability of dying of YF, pyf 
(p)
 
is the probability of getting the infection if not vacci-
nated, pv(p) is the probability of receiving the vaccine dur-
ing the outbreak and d*v  (p) is the probability of developing 
serious adverse events (including death) from the vaccine 
received during the outbreak. The quantity dv , the risk of 
vaccine-induced fatality rate, was assumed to be equal to 
5.0 x 10-6 doses-1, which was the value observed in 2009 in 
the region of Botucatu (Mascheretti et al. 2013). The risk 
of outbreak (r) is described below. The quantities dyf (p), pyf 
(p), pv(p) and d*v  (p) were calculated through a dynamic system described in The dynamical system, Supplemen-
tary data. Therefore, we are considering the possibility of 
vaccination before and during an eventual outbreak.
The term Nh pdv in equation is the number of seri-
ous adverse events (including deaths) of those individu-
als pre-emptively vaccinated in campaigns before out-
breaks. The second term in equation, Nhr(1- p)[(dyf (p) - d
*
v 
(p))pyf (p) + pv(p)d*v  (p)] is the number of serious adverse 
events (including deaths) after an outbreak, due to death 
by YF infection and of serious adverse events (including 
deaths) due to vaccination during the outbreak.
We then minimise D(p) on the unit interval (0 ≤ p ≤ 
1) to determine the group optimum, pgr,which is the cover- 
age level that would have to be imposed to minimise 
the total expected number of serious adverse events 
(including deaths).
The results of the equation simulation (Table I) are 
presented in Figs 1-3, considering the risk of vaccine-
induced fatality rate of 5.0 x 10-6 dose-1 observed in 2009 
in the region of Botucatu (Mascheretti et al. 2013) for 
various estimated risks of outbreaks (see below).
We then applied the Delphi method to estimate 
the potential risk of outbreaks in several regions of SP 
(Dalkey & Helmer 1963, Massad et al. 1999, Ortega et 
al. 2003). The method was originally developed as a sys-
tematic, interactive forecasting method which relies on 
a panel of experts. The experts answer questionnaires in 
two or more rounds. After each round, a facilitator pro-
vides an anonymous summary of the experts’ forecasts 
from the previous round as well as the reasons they pro-
vide for their judgments. Therefore, experts are encour-
aged to revise their earlier answers based on the replies 
of other members of their panel. During this process, the 
range of the answers will decrease and the group will 
converge towards the “correct” answer. Finally, the pro-
cess is stopped after a pre-defined stop criterion (e.g., 
number of rounds, achievement of consensus and stabil-
TABLE I
Parameters used in the simulations of modela
Parameter Biological meaning Value
a Mosquitoes’ biting rate 0.78 day-1
b Probability of transmission from infected  
mosquitoesto susceptible humans
1.0
gh Inverse of the intrinsic incubation period in humans 0.14 day-1
mh Natural mortality rate of humans 3.91 x 10-5 day-1
ah Yellow fever (YF)-induced mortality rate in humans 0.1 day-1
nh YF vaccination rate 10-5 day-1
mv Vaccine-induced mortality rate 2.1 x 10-10 day-1
c Probability of transmission from infected  
humans to susceptible mosquitoes
1.0
mM Natural mortality rate of mosquitoes 0.15 day-1
aM YF-induced mortality rate in mosquitoes 0
t Extrinsic incubation period in mosquitoes 7 days
p Proportion of preemptive vaccination Variable
a: The dynamical system (Supplementary data).
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ity of results) and the mean or median scores of the final 
rounds determine the results.
During four meetings, the professionals of epide-
miological surveillance, laboratory, vector control and 
the environment of the Centre of Epidemiological Sur-
veillance, Adolpho Lutz Institute, Superintendence of 
Endemics Control and São Paulo Secretariat of the En-
vironment discussed the risk of introduction of YF in 
new regions. We evaluated and assigned a score to de-
fine the risk in the epidemiological surveillance groups 
without recommendation of vaccination. The following 
variables were scored as 0, +1 or +2: presence of sylvatic 
Fig. 1: simulation of model (The dynamical system, Supplementary 
data) showing that the parameters chosen reproduce, in the equilib-
rium, the observed risk of vaccine-induced death after the Botucatu 
outbreak. The time scale is not relevant because the intent is just to 
demonstrate that the vaccination rate applied determined a lethality at 
equilibrium compatible with the one observed.
Fig. 2: simulation of model (The dynamical system, Supplementary 
data) showing that the parameters chosen reproduce, in the equi-
librium, the observed number of YF cases and deaths during the 
Botucatu outbreak.
TABLE II
Variables and values attributed by the Secretary of Health of the State of São Paulo staff through the Delphi method
Region
Variables
TotalA B C D E F G H I J K L
Capital 1 1 2 1 0 1 1 2 2 0 0 -2 9
Santo André 1 1 1 1 0 1 1 2 2 0 0 -1 9
Mogi das Cruzes 1 1 2 1 0 1 1 2 2 0 0 -1 10
Franco da Rocha 1 1 2 1 0 1 1 2 2 0 0 0 11
Osasco 1 2 2 1 0 1 1 1 2 0 0 -1 10
Botucatu 2 2 2 2 2 2 2 2 2 2 2 0 22
Campinas 2 1 2 2 1 1 1 2 1 1 0 0 14
Piracicaba 2 2 1 2 2 2 1 1 0 2 0 0 15
Registro 2 1 2 1 1 2 1 2 2 2 2 0 18
Santos 2 2 2 2 0 2 1 2 2 0 0 -1 14
São João da Boa Vista 2 1 1 1 2 1 1 2 1 2 1 0 15
São José dos Campos 2 1 2 1 1 0 0 1 1 0 0 0 9
Taubaté 1 1 2 1 1 0 0 2 2 1 1 0 12
Sorocaba 2 2 2 1 2 1 1 2 1 2 2 0 18
Caraguatatuba 2 2 2 2 0 2 1 2 2 0 0 0 15
A: presence of sylvatic vectors; B: presence of Aedes aegypti; C: presence of non-human primates; D: cases of dengue; E: river 
basins; F: climatic conditions; G: landscape; H: vegetation; I: fragmentation; J: proximity to the area of vaccine recommendation; 
K: rural population; L: urbanization density.
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vector, presence of Ae. aegypti, presence of non-human 
primates, dengue cases, river basin, climatic conditions, 
landscape, vegetation, fragmentation, proximity to the 
area of vaccine recommendation and rural population. 
The urbanisation density, the number of buildings per 
area of each region, was represented by the scores 0, -1 
or -2. The eventual presence of non-explained deaths of 
non-human primates in any of the regions was not in-
cluded in the risk analysis because, according to the cur-
rent vaccination policy, if the non-human primate corpse 
is negative for the YF virus, then the risk is considered 
zero. If, in contrast, it is positive for YF, then the risk is 
considered 100% and the vaccination recommendation 
strategy is triggered. The results are shown in Table II.
Based on the Delphi scores, it was possible to esti-
mate the relative risks of outbreaks for each region using 
the case of Botucatu as a reference. The risk assigned to 
Botucatu was equal to 40% or 0.4. This value was cho-
sen because it is the minimum risk that resulted in 100% 
optimum vaccination coverage. In other words, the value 
of the risk assigned to Botucatu was such that no other 
risk value greater than that results in optimum coverage 
less than 100%. Therefore, it is the minimum risk that has 
100% of coverage as the optimum level. According to Fig. 
3B, we see that for 0% of vaccination, the total mortal-
ity in Botucatu (uppermost line) is approximately 11 (the 
actual observed value) and for 100% it was five (also the 
actual observed number of deaths due to the vaccine). All 
the other risks attributed to the regions were calculated as 
a linear proportion of the reference risk assigned to Botu-
catu. The results are shown in Supplementary Table I.
Fig. 4 shows the map of SP with the proposed optimal 
vaccination strategies for the unaffected areas. The calcu-
lated optimum proportion for vaccination against YF ac-
cording to model (The dynamical system, Supplementary 
data) is shown in Supplementary Table II and Fig. 3A, B.
DISCUSSION
Since its reintroduction in Brazilian regions in 1976, 
Ae. aegypti spread throughout the country, infesting 
more than 80% of urban centres (Costa et al. 2011).
The current circulation of YF virus in SP was as-
sociated with the high mobility of susceptible humans 
to enzootic YF areas. The virus eventually returned as 
viraemia to the Ae. aegypti infested home cities, which 
represents an enormous risk for urban YF re-emergence. 
Vaccination, therefore, is the main tool available to pre-
vent the catastrophe represented by the re-emergence of 
urban YF. Even if we consider an unprecedented high 
rate of serious vaccine-induced adverse effects similar 
to the one observed in the Botucatu outbreak, vaccinat-
ing a high proportion of susceptible people in still unaf-
fected areas should be indicated.
Presently, the surveillance policy against YF by the 
Brazilian Ministry of Health consists of maintaining 
high vaccination coverage of the so-called “recommen-
dation” areas (dark green in Fig. 4) and triggering a mass 
vaccination action intended to cover entire areas where 
virus circulation is detected either in humans or non-hu-
man primates. This type of indiscriminate vaccination 
policy is far from optimum and therefore, an analysis 
such as the one proposed in this paper could help opti-
mise the vaccination coverage necessary in each area.
Our results were based on the high level of vaccine-in-
duced mortalities never observed before. If we consider the 
more accepted levels of vaccine-induced mortality propor-
tions such as 2.5 deaths per one million doses as in Massad 
et al. (2005), the optimum vaccination doses required for 
minimising the total probability of death would be even 
higher than the levels we are proposing for the still unaf-
fected areas. It is important to emphasise, however, that the 
aim of this paper was to propose a methodology to estimate 
the optimum vaccination strategies that would minimise 
the death both by the disease and by the vaccine.
In addition to the vaccine-induced mortality frequen-
cy, another critical parameter considered by our model 
is the expected risk of outbreak. We applied a relatively 
simple method for estimating those risks, but a more so-
phisticated analysis of the outbreak risk for each unaf-
fected area would refine our results. Moreover, our model 
assumes various oversimplifications of the dynamics of 
YF such as the absence of an age component in trans-
mission and several other sources of heterogeneities. The 
Fig. 3: results of the simulation of D(p) / Nh from equation (main text), 
representing the per capita probability of death either by the disease or the 
vaccine. A: the three-dimensional figure showing D(p) / Nh as a function 
of proportion of preemptive vaccination, p, and the risk of outbreak, r; B: 
a profile of A, with only the risk of outbreaks, as in Supplementary Table 
II. The red triangles correspond to the minimum values of each curve.
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Fig. 4: map of the state of São Paulo with the proposed optimal vaccination strategies for the unaffected areas. “Recommended” 
means indiscriminate vaccination of 100% of the area.
quality of the data used, collection system and its accura-
cy of association between vaccination and related deaths 
are weaknesses of our estimations. Our work, therefore, 
should be viewed as a methodological proposal rather 
than a definitive public health intervention policy.
If a vaccination strategy such as the one proposed in 
this paper is actually implemented in the regions where 
the optimum vaccination proportion is less than 100%, 
then the fraction of the population that should be vacci-
nated would be calculated by fractioning the risk region-
ally within the area.
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